First Header Logo Second Header Logo

Connection

Mark Espeland to Early Termination of Clinical Trials

Back to Details
This is a "connection" page, showing publications Mark Espeland has written about Early Termination of Clinical Trials.
Mark Espeland
Connection Strength
0.093
Early Termination of Clinical Trials
  1. Espeland MA, Brunner RL, Hogan PE, Rapp SR, Coker LH, Legault C, Granek I, Resnick SM. Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension. J Am Geriatr Soc. 2010 Jul; 58(7):1263-71.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.